These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8142301)
1. Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073). Di Salle E; Briatico G; Giudici D; Ornati G; Panzeri A J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):241-8. PubMed ID: 8142301 [TBL] [Abstract][Full Text] [Related]
2. Hormonal effects of turosteride, a 5 alpha-reductase inhibitor, in the rat. di Salle E; Giudici D; Briatico G; Ornati G; Panzeri A J Steroid Biochem Mol Biol; 1993 Nov; 46(5):549-55. PubMed ID: 8240976 [TBL] [Abstract][Full Text] [Related]
3. Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma. Zaccheo T; Giudici D; di Salle E Prostate; 1997 Feb; 30(2):85-91. PubMed ID: 9051146 [TBL] [Abstract][Full Text] [Related]
4. CGP 53153: a new potent inhibitor of 5alpha-reductase. Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628 [TBL] [Abstract][Full Text] [Related]
5. 17 beta-acylurea derivatives of 4-azasteroids as inhibitors of testosterone 5 alpha-reductase. Di Salle E; Briatico G; Giudici D; Ornati G; Nesi M; Panzeri A J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):765-8. PubMed ID: 1373305 [TBL] [Abstract][Full Text] [Related]
6. Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats. Zaccheo T; Giudici D; di Salle E Prostate; 1998 Jun; 35(4):237-42. PubMed ID: 9609545 [TBL] [Abstract][Full Text] [Related]
7. Novel aromatase and 5 alpha-reductase inhibitors. Di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T; Buzzetti F; Nesi M; Panzeri A J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):289-94. PubMed ID: 8043491 [TBL] [Abstract][Full Text] [Related]
8. PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor. di Salle E; Giudici D; Radice A; Zaccheo T; Ornati G; Nesi M; Panzeri A; Délos S; Martin PM J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):179-86. PubMed ID: 9605412 [TBL] [Abstract][Full Text] [Related]
9. The biological activity of 7 alpha-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone. Kumar N; Didolkar AK; Monder C; Bardin CW; Sundaram K Endocrinology; 1992 Jun; 130(6):3677-83. PubMed ID: 1597164 [TBL] [Abstract][Full Text] [Related]
10. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates. Hirosumi J; Nakayama O; Chida N; Inami M; Fagan T; Sawada K; Shigematsu S; Kojo H; Notsu Y; Okuhara M J Steroid Biochem Mol Biol; 1995 Apr; 52(4):365-73. PubMed ID: 7734405 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia. Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613 [TBL] [Abstract][Full Text] [Related]
13. FCE 28260, a new 5 alpha-reductase inhibitor: in vitro and in vivo effects. Giudici D; Briatico G; Cominato C; Zaccheo T; Iehlè C; Nesi M; Panzeri A; di Salle E J Steroid Biochem Mol Biol; 1996 Jun; 58(3):299-305. PubMed ID: 8836165 [TBL] [Abstract][Full Text] [Related]
14. Molecular interactions of progesterone derivatives with 5 alpha-reductase types 1 and 2 and androgen receptors. Bratoeff E; García P; Heuze Y; Soriano J; Mejía A; Labastida AM; Valencia N; Cabeza M Steroids; 2010 Jul; 75(7):499-505. PubMed ID: 20359488 [TBL] [Abstract][Full Text] [Related]
15. FR146687, a novel steroid 5 alpha-reductase inhibitor: in vitro and in vivo effects on prostates. Nakayama O; Hirosumi J; Chida N; Takahashi S; Sawada K; Kojo H; Notsu Y Prostate; 1997 Jun; 31(4):241-9. PubMed ID: 9180934 [TBL] [Abstract][Full Text] [Related]
16. Feedback regulation of gonadotropins by androgens in rats: is 5 alpha-reduction involved? Kumar N; Sundaram K; Bardin CW J Steroid Biochem Mol Biol; 1995 Jan; 52(1):105-12. PubMed ID: 7857869 [TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay for the testosterone 5 alpha-reductase inhibitor turosteride in biological fluids. Persiani S; Broutin F; Pianezzola E; Panzeri A; Fonte G; Fontana E; Strolin Benedetti M J Immunoassay; 1994 May; 15(2):97-113. PubMed ID: 8040353 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression. Cohen SM; Werrmann JG; Rasmusson GH; Tanaka WK; Malatesta PF; Prahalada S; Jacobs JG; Harris G; Nett TM Prostate; 1995 Feb; 26(2):55-71. PubMed ID: 7531846 [TBL] [Abstract][Full Text] [Related]
19. Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat. di Salle E; Giudici D; Biagini L; Cominato C; Briatico G; Panzeri A J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):381-5. PubMed ID: 7626485 [TBL] [Abstract][Full Text] [Related]
20. Determination of turosteride, a new inhibitor of 5 alpha-reductase, in human plasma by high-performance liquid chromatography with ultraviolet detection. Basileo G; Casati M; Pianezzola E; Strolin Benedetti M J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(1):117-25. PubMed ID: 9029321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]